PATENT CLAIM ANALYSIS

Application Number: 15950065
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "212040"]

Abstract:
The present disclosure provides crystalline Compound I and crystalline Compound II, pharmaceutical compositions comprising one of said crystalline compounds suitable for intratympanic administration, and methods for treating otic disorders using the crystalline compounds and the pharmaceutical compositions.

Claim (Index 24):
The method of  claim 23 , wherein the otic disorder is hearing loss.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 91.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12837286', '13928157', '14469408', '12506616', '11731663']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7217894375929259
- 35 USC 102 Novelty (BERT): 0.5224976385163971
- Combined Prediction Score: 0.701860257685273
- Mean Citation Score: 244.283842
- Max Citation Score: 256.07574
- Similarity Product: 152.88988605455876

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test